[Grand Opening] Dr. Hu Junyuan, Chairman of Beike Biotech, attended the 2021 Cell Industry Conference
Posted on
On October 26, 2021, the 2021 Cell Industry Conference/2021 Seventh (Shenzhen) Cell and Tumor Precision Medicine Summit Forum and the 2021 Gene and Precision Diagnosis and Treatment (Shenzhen) Summit Forum opened in Shenzhen. Hu Junyuan, chairman of Beike Biotech and president of Shenzhen Life Sciences Industry Association, was invited to attend the summit forum and make a special report.
The Cell Industry Conference has been successfully held for six times. Through continuous exploration, development, accumulation and precipitation, it has grown into a major event in the domestic cell industry. This summit focuses on topics such as policy norms, supervision, technology and industrialization progress, cell and gene therapy, 3D cell culture and organoids, oncolytic viruses, solid tumor treatment and drug development, clinical research and treatment progress, etc. Authoritative experts and industry pioneers from national drug review and regulatory agencies, scientific research institutes, medical institutions, innovative pharmaceutical companies, biotherapy, biotechnology and service companies, upstream and downstream enterprises in the industrial chain, industrial parks, investment institutions, industry associations, etc. are specially invited to share, communicate and display products with industry pioneers.
The chairman of Beike Biotech was invited to give a special speech via voice connection. Dr. Hu Junyuan mentioned, Faced with the wave of the intelligent and digital era, Beike Biotech has always advocated the path of intelligent transformation in terms of cell R&D technology innovation and cell production standardization. Driven by artificial intelligence and innovative research and development, Beike Biotech is making steady progress in the direction of intelligence in cell industry manufacturing, technology research and development, and clinical transformation. Dr. Liao Yan, manager of Beike Biotechnology R&D Center, also gave a wonderful speech at the summit on the theme of “The Development of Stem Cell Therapy Industry – Prospects of Basic and Translational Applications”.
